Suppr超能文献

Epstein Barr 病毒 Rta 肽-HLA 复合物亚最优病毒片段的晶体结构,可刺激 CD8 T 细胞反应。

Crystal structure of suboptimal viral fragments of Epstein Barr Virus Rta peptide-HLA complex that stimulate CD8 T cell response.

机构信息

Singapore Immunology Network, 8A Biomedical Grove, #03-06 Immunos, Singapore, 138648, Singapore.

Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, 5 Science Drive 2, Singapore, 119260, Singapore.

出版信息

Sci Rep. 2019 Nov 13;9(1):16660. doi: 10.1038/s41598-019-53201-6.

Abstract

Peptides presented by Human leukocyte antigen (HLA) class-I molecules are generally 8-10 amino acids in length. However, the predominant pool of peptide fragments generated by proteasomes is less than 8 amino acids in length. Using the Epstein - Barr virus (EBV) Rta-epitope (ATIGTAMYK, residues 134-142) restricted by HLA-A11:01 which generates a strong immunodominant response, we investigated the minimum length of a viral peptide that can constitute a viral epitope recognition by CD8 T cells. The results showed that Peripheral blood mononuclear cells (PBMCs) from healthy donors can be stimulated by a viral peptide fragment as short as 4-mer (AMYK), together with a 5-mer (ATIGT) to recapitulate the full length EBV Rta epitope. This was confirmed by generating crystals of the tetra-complex (2 peptides, HLA and β2-microglobulin). The solved crystal structure of HLA-A11:01 in complex with these two short peptides revealed that they can bind in the same orientation similar to parental peptide (9-mer) and the free ends of two short peptides acquires a bulged conformation that is directed towards the T cell receptor. Our data shows that suboptimal length of 4-mer and 5-mer peptides can complement each other to form a stable peptide-MHC (pMHC) complex.

摘要

由人类白细胞抗原(HLA)I 类分子呈递的肽通常长 8-10 个氨基酸。然而,蛋白酶体生成的肽片段主要池小于 8 个氨基酸。使用受 HLA-A11:01 限制的 Epstein-Barr 病毒(EBV)Rta 表位(ATIGTAMYK,残基 134-142),该表位产生强烈的免疫优势反应,我们研究了构成 CD8 T 细胞识别的病毒表位的病毒肽的最小长度。结果表明,来自健康供体的外周血单核细胞(PBMC)可以被短至 4 聚体(AMYK)的病毒肽片段刺激,同时与 5 聚体(ATIGT)一起重新产生全长 EBV Rta 表位。通过生成四复合物(2 个肽,HLA 和β2-微球蛋白)证实了这一点。与这两个短肽形成复合物的 HLA-A11:01 的解决晶体结构表明,它们可以以类似于亲本肽(9 聚体)的相同方向结合,并且两个短肽的自由端获得朝向 T 细胞受体的凸起构象。我们的数据表明,次优长度的 4 聚体和 5 聚体肽可以互补形成稳定的肽-MHC(pMHC)复合物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9260/6853878/5c200bff5e08/41598_2019_53201_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验